Fisiopatología y relevancia clínica de los monocitos en la fibrosis pulmonar idiopática: revisión narrativa
Respirar · 06.03.2026 · 18 (1)
DOI: 10.55720/respirar.18.1.14 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirar, online erschienen am 06.03.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Interstitial lung diseases are a heterogeneous group of disorders characterized by variable degrees of inflammation and fibrosis. Idiopathic pulmonary fibrosis (IPF) is one of the most common types of lung fibrosis and is linked to a poor prognosis. Several biomarkers have been developed to help doctors predict early on the disease’s course and how well it will respond to treatment. The pathogenesis of fibrotic disease aberrantly implicates monocytes. This process, where monocyte precursors grow in the bone marrow and monocytes move to other tissues, is a lot like alveolar macrophages. CCR2 is the receptor necessary for the classical migration of monocytes to inflamed tissues. This chemokine, monocyte chemoattractant protein 1 (MCP-1, also called CCL2), binds to CCR2 better than any other. Activated monocytes have been found in IPF patients. Patients with activated monocytes can produce profibrotic proteins. Research has linked high blood monocyte counts to the progression of IPF and an increased risk of death.
Zitieren
APA
(2026). Fisiopatología y relevancia clínica de los monocitos en la fibrosis pulmonar idiopática: revisión narrativa. Respirar, 18(1). https://doi.org/10.55720/respirar.18.1.14
Vancouver
Fisiopatología y relevancia clínica de los monocitos en la fibrosis pulmonar idiopática: revisión narrativa. Respirar. 2026;18(1). doi:10.55720/respirar.18.1.14
BibTeX
@article{euvimed2026,
title = {Fisiopatología y relevancia clínica de los monocitos en la fibrosis pulmonar idiopática: revisión narrativa},
journal = {Respirar},
year = {2026},
volume = {18},
number = {1},
doi = {10.55720/respirar.18.1.14}
}
EUVIMED